This inventor holds 3 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bacainn Biotherapeutics, Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Roland E Dolle: Innovator in Cyclosporine Research
Introduction
Roland E Dolle is a notable inventor based in Eureka, MO (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of cyclosporine compounds. With a total of 3 patents, his work focuses on innovative methods for treating inflammation.
Latest Patents
Dolle's latest patents include compositions and methods for the use of cyclosporine in the treatment or prevention of neutrophil-mediated inflammation. These patents disclose cyclosporine compounds that inhibit the activity of MRP2 and FPRL, showcasing his commitment to advancing medical treatments.
Career Highlights
Dolle is currently associated with Bacainn Biotherapeutics, Ltd., where he continues to push the boundaries of biotherapeutic research. His work has the potential to impact the treatment of various inflammatory conditions, making him a key figure in his field.
Collaborations
Some of his notable coworkers include Chris Murphy and Ronald Farquhar, who contribute to the innovative environment at Bacainn Biotherapeutics, Ltd.
Conclusion
Roland E Dolle's contributions to cyclosporine research exemplify his dedication to innovation in biotherapeutics. His patents and ongoing work are paving the way for new treatments in inflammation management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile